Vimkunya 40 MCG/0.8 ML syringe 0.8ML
Ended Awarded
- Contract number
- SPE2DB25FLPAP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,060
Award facts
- Contract value 100% obligated
- $10,060.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,060 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Vimkunya 40 mcg/0.8 ml syringes. This delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, carries no set-aside designation. The contract represents a single delivery transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its extensive portfolio of delivery orders from the Defense Logistics Agency, spanning prescription medications, biologics, vaccines, and medical consumables. The company's federal contracting experience demonstrates consistent success in competing for pharmaceutical procurement opportunities supporting Department of Defense healthcare operations nationwide. This delivery order for Vimkunya syringes continues the contractor's established role in supplying injectable pharmaceutical products to military medical facilities, leveraging its SAM.gov registration dating to 2001 and woman-owned small business status.
Quick answers
Who was awarded contract SPE2DB25FLPAP?
SPE2DB25FLPAP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FLPAP worth?
The government has obligated $10,060 on SPE2DB25FLPAP.
Is contract SPE2DB25FLPAP an order under another contract?
Yes. SPE2DB25FLPAP is a delivery order under SPE2DB25D9302, an indefinite delivery contract.
Was contract SPE2DB25FLPAP competed?
The extent of competition for SPE2DB25FLPAP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award